Minerva Neurosciences Inc (NERV) 13F Ownership Report (Q2 2026)

NERV ranks #5737 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

NERV is a top-conviction position for Ally Bridge Group — at 10.7% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in NERV belongs to Federated Hermes, Inc., but the position matters far more to Ally Bridge Group, who has 10.7% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

BlackRock has added to its NERV position for two straight quarters, increasing it by $12.1M to reach $12.4M today.

Adage Capital Partners Gp, L.l.c. has trimmed its NERV position for two straight quarters, cutting it by $3.5M while still holding $7.9M.

NERV is down 5.7% today, but institutions show net buying of $29.8M this quarter — a divergence between today's price move and the underlying institutional flow.

NERV reported a net loss of $394.3M over the trailing twelve months.

• Not yet profitable — net loss of $394.3M over the trailing twelve months
• Revenue declined 100.0% year over year
• Net income declined year over year, from $11.2M to -$394.3M
• Operating cash flow was negative, using $13.5M in cash
• Current ratio of 36.28x — enough short-term assets to cover short-term liabilities